Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 4
Submit an article Journal homepage
1,069
Views
41
CrossRef citations to date
0
Altmetric
Meeting Report

Improving the managed entry of new medicines: sharing experiences across Europe

Brian Godman Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, Stockholm, Sweden. [email protected]; Mario Negri Institute for Pharmacological Research, Milan, Italy; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, UK; Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, Stockholm, Sweden. [email protected]; Mario Negri Institute for Pharmacological Research, Milan, Italy; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, UK
,
Ken Paterson Scottish Medicines Consortium, Glasgow, UK; Scottish Medicines Consortium, Glasgow, UK
,
Rickard E Malmström Department of Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden
,
Gisbert Selke Wissenschaftliches Institut der AOK (WidO), Berlin, Germany; Wissenschaftliches Institut der AOK (WidO), Berlin, Germany
,
Jean-Paul Fagot Département des études sur les pathologies et les patients (DEPP), Direction de la Stratégie, des Etudes et des Statistiques (DSES), Caisse Nationale d’Assurance Maladie des Travailleurs Salariés, Paris, France; Département des études sur les pathologies et les patients (DEPP), Direction de la Stratégie, des Etudes et des Statistiques (DSES), Caisse Nationale d’Assurance Maladie des Travailleurs Salariés, Paris, France
&
Jana Mrak Health Insurance Institute of Slovenia, Ljubljana, Slovenia; Health Insurance Institute of Slovenia, Ljubljana, Slovenia
Pages 439-441 | Published online: 09 Jan 2014

References

  • Godman B, Shrank W, Andersen M et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilisation: changes seen and global implications. Expert Rev. Pharmacoecon. Outcomes Res. 10, 707–722 (2010).
  • Garattini S, Bertele V, Godman B et al. Enhancing the rational use of new medicines across European healthcare systems – a position paper. Eur. J. Clin. Pharmacol. 64, 1137–1138 (2008).
  • Kaiser J. New cystic fibrosis drug offers hope, at a price. Science 335, 645 (2012).
  • Wettermark B, Godman B, Eriksson C et al. [Introduction of new medicines into European healthcare systems]. GGW 10(3), 24–34 (2010).
  • Godman B, Bucsics A, Burkhardt T et al. Insight into recent reforms and initiatives in Austria; implications for key stakeholders. Expert Rev. Pharmacoecon. Outcomes Res. 8, 357–371 (2008).
  • Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier JP. Ongoing pharmaceutical reforms in France; implications for key stakeholder groups. Appl. Health Econ. Health Policy 8, 7–24 (2010).
  • Wettermark B, Persson M, Wilking N et al. Forecasting drug utilization and expenditure in a metropolitan health region. BMC Health Services Res. 10, 128 (2010).
  • Harper P, Young L, Merriman E. Bleeding risk with dabigatran in the frail elderly. N. Engl. J. Med. 366, 864–866 (2012).
  • Mannuci M, Nobil A, Garattini S. New drugs for thromboprophylaxis in atrial fibrillation. Eur. J. Int. Med. 23, 1–5 (2012).
  • Malmstrom RE. New anticoagulants. In: Essential Guide to Blood Coagulation. Antovic JP, Blomback M (Eds). Wiley-Blackwell Publishing, Oxford, UK, 91–102 (2009).
  • Joppi R, Dematte L, Menti AM, Pase D, Poggiani C, Mezzalira L; Italian Horizon Scanning Project Group. The Italian Horizon Scanning Project. Eur. J. Clin. Pharmacol. 65(8), 775–781 (2009).
  • Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine – selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326, 1171 (2003).
  • Adamski J, Godman B, Ofierska-Sujkowska G et al. Review of risk sharing schemes for pharmaceuticals: considerations, critical evaluation and recommendations for European payers. BMC Health Servic. Res. 10, 153 (2010).
  • Gustafsson LL, Wettermark B, Godman B et al. The ‘Wise List’ – a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin. Pharmacol. Toxicol. 108, 224–233 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.